MISTY D NEISEN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant BOISE, ID NPI 1023409265
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ID Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,200.13
- Category: General Payments
- Program years: PY2021–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $650.89 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $650.89 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $250.51 | 3 |
| Myriad Genetic Laboratories, Inc. | $153.25 | 2 |
| PFIZER INC. | $100.80 | 1 |
| CONMED Corporation | $85.91 | 1 |
| GlaxoSmithKline, LLC. | $60.42 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104723821 | AstraZeneca Pharmaceuticals LP | $115.10 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105456818 | AstraZeneca Pharmaceuticals LP | $108.10 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105746405 | AstraZeneca Pharmaceuticals LP | $27.31 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116376912 | GlaxoSmithKline, LLC. | $60.42 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131482621 | PFIZER INC. | $100.80 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142403086 | CONMED Corporation | $85.91 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152549316 | Myriad Genetic Laboratories, Inc. | $91.41 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152549320 | Myriad Genetic Laboratories, Inc. | $61.84 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.